Literature DB >> 30794328

NK cell immune responses differ after prime and boost vaccination.

Jean-Louis Palgen1,2, Nicolas Tchitchek1,2, Nicolas Huot2,3, Jamila Elhmouzi-Younes1,2, Cécile Lefebvre2,4, Pierre Rosenbaum1,2, Nathalie Dereuddre-Bosquet1,2, Frédéric Martinon1,2, Hakim Hocini2,4, Antonio Cosma1,2, Michaela Müller-Trutwin2,3, Yves Lévy2,4, Roger Le Grand1,2, Anne-Sophie Beignon1,2.   

Abstract

A better understanding of innate responses induced by vaccination is critical for designing optimal vaccines. Here, we studied the diversity and dynamics of the NK cell compartment after prime-boost immunization with the modified vaccinia virus Ankara using cynomolgus macaques as a model. Mass cytometry was used to deeply characterize blood NK cells. The NK cell subphenotype composition was modified by the prime. Certain phenotypic changes induced by the prime were maintained over time and, as a result, the NK cell composition prior to boost differed from that before prime. The key phenotypic signature that distinguished NK cells responding to the boost from those responding to the prime included stronger expression of several cytotoxic, homing, and adhesion molecules, suggesting that NK cells at recall were functionally distinct. Our data reveal potential priming or imprinting of NK cells after the first vaccine injection. This study provides novel insights into prime-boost vaccination protocols that could be used to optimize future vaccines. ©2019 Society for Leukocyte Biology.

Entities:  

Keywords:  MVA; NHP; NK cells; innate lymphoid immunity; mass cytometry; prime-boost; transcriptomics; vaccination

Mesh:

Substances:

Year:  2019        PMID: 30794328     DOI: 10.1002/JLB.4A1018-391RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

1.  Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations.

Authors:  Jean-Louis Palgen; Nicolas Tchitchek; André Rodriguez-Pozo; Quentin Jouhault; Hadjer Abdelhouahab; Nathalie Dereuddre-Bosquet; Vanessa Contreras; Frédéric Martinon; Antonio Cosma; Yves Lévy; Roger Le Grand; Anne-Sophie Beignon
Journal:  NPJ Vaccines       Date:  2020-03-19       Impact factor: 7.344

2.  Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire.

Authors:  Elena Vendrame; Julia L McKechnie; Thanmayi Ranganath; Nancy Q Zhao; Arjun Rustagi; Rosemary Vergara; Geoffrey T Ivison; Lisa M Kronstad; Laura J Simpson; Catherine A Blish
Journal:  J Vis Exp       Date:  2020-11-19       Impact factor: 1.355

3.  HLA-B*57:01 Complexed to a CD8 T-Cell Epitope from the HSV-2 ICP22 Protein Binds NK and T Cells through KIR3DL1.

Authors:  Kerry J Laing; Victoria L Campbell; Lichun Dong; David M Koelle
Journal:  Viruses       Date:  2022-05-11       Impact factor: 5.818

Review 4.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

5.  SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity.

Authors:  Nicolas Huot; Philippe Rascle; Caroline Petitdemange; Vanessa Contreras; Christina M Stürzel; Eduard Baquero; Justin L Harper; Caroline Passaes; Rachel Legendre; Hugo Varet; Yoann Madec; Ulrike Sauermann; Christiane Stahl-Hennig; Jacob Nattermann; Asier Saez-Cirion; Roger Le Grand; R Keith Reeves; Mirko Paiardini; Frank Kirchhoff; Beatrice Jacquelin; Michaela Müller-Trutwin
Journal:  Nat Commun       Date:  2021-02-24       Impact factor: 14.919

Review 6.  Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game.

Authors:  Jean-Louis Palgen; Yanis Feraoun; Gaëlle Dzangué-Tchoupou; Candie Joly; Frédéric Martinon; Roger Le Grand; Anne-Sophie Beignon
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 7.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01

8.  Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations.

Authors:  Jean-Louis Palgen; Nicolas Tchitchek; André Rodriguez-Pozo; Quentin Jouhault; Hadjer Abdelhouahab; Nathalie Dereuddre-Bosquet; Vanessa Contreras; Frédéric Martinon; Antonio Cosma; Yves Lévy; Roger Le Grand; Anne-Sophie Beignon
Journal:  NPJ Vaccines       Date:  2020-03-19       Impact factor: 7.344

Review 9.  Memory and Memory-Like NK Cell Responses to Microbial Pathogens.

Authors:  Marc Brillantes; Aimee M Beaulieu
Journal:  Front Cell Infect Microbiol       Date:  2020-03-25       Impact factor: 5.293

10.  Non-human Primate Determinants of Natural Killer Cells in Tissues at Steady-State and During Simian Immunodeficiency Virus Infection.

Authors:  Nicolas Huot; Philippe Rascle; Caroline Petitdemange; Vanessa Contreras; Jean-Louis Palgen; Christiane Stahl-Hennig; Roger Le Grand; Anne-Sophie Beignon; Beatrice Jacquelin; Michaela Müller-Trutwin
Journal:  Front Immunol       Date:  2020-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.